Insider filing · APGE
Carl Dambkowski
Director
profile →
Apogee Therapeutics, Inc.
APGE · Healthcare · 47 filings in 24 months
ticker →
Carl Dambkowski sold $1.4M of Apogee Therapeutics (APGE)
Executed Jan 7, disclosed Jan 9, 2 days later.
Value, as filed
$1.4M
17,774 sh across 2 lots
Executed
Jan 7
the trade date, as filed
Disclosed
Jan 9
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CDCarl Dambkowski (Director) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $6.2M of ORKA (105,000 sh across 3 lots, as filed), executed May 21.
The name
APGEHealthcare · Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Carl Dambkowski in APGE
APGESALE
Apogee Therapeutics, Inc.
$738K5,500 sh × $134.17
Exec Aug 5
Filed Aug 7 · 8:00 PM ET APGESALE Apogee Therapeutics, Inc. $730K
5,500 sh × $132.74
Exec Jul 1
Filed Jul 2 · 8:13 PM ET APGESALE Apogee Therapeutics, Inc. $3.5M
26,400 sh × $132.60
Exec Jun 22
Filed Jun 24 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $433K
5,500 sh × $78.71
Exec Jun 3
Filed Jun 5 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $463K
5,500 sh across 2 lots
Exec May 6
Filed May 8 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $458K
5,400 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $376K
5,300 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $161K
2,481 sh × $64.88
Exec Feb 4
Filed Feb 4 · 5:30 PM ET